DETAILED NOTES ON SITUS JUDI MBL77

mutations specified the fact that, as stated below, CLL therapy is predicated within the existence or absence of these mutations. The current consensus is usually that, other than clonal mutations, subclonal mutations with a variant allelic frequency starting from 5 to ten% (and for that reason under the brink of detection by standard molecular str